Table 3.
Additional information about the dogs with positive PCR results concerning their subgroup of age, source of positive sample material and onset of signs
| Pathogen | Group | Total diseased dogs (n=214) | A (n=173) | B (n=41) | C (n=50) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRCoV | Dogs (n) | 16 | 9 | 7 | 2 | ||||||||
| Puppies/adolescent/adult (n) | 1 | 9 | 6 | 0 | 4 | 5 | 1 | 5 | 1 | 0 | 1 | 1 | |
| Nose/tonsils/both (n) | 9 | 2 | 5 | 5 | 1 | 3 | 4 | 1 | 2 | 1 | 0 | 1 | |
| Acute/chronic (n) | 15 | 1 | 8 | 1 | 7 | 0 | – | – | |||||
| CPiV | Dogs (n) | 14 | 11 | 3 | 0 | ||||||||
| Puppies/adolescent/adult (n) | 4 | 3 | 7 | 4 | 3 | 4 | 0 | 0 | 3 | ||||
| Nose/tonsils/both (n) | 13 | 0 | 1 | 10 | 0 | 1 | 3 | 0 | 0 | ||||
| Acute/chronic (n)* | 12 | 1 | 9 | 1 | 3 | 0 | |||||||
| CAV‐2 | Dogs (n) | 1 | 1 | 0 | 0 | ||||||||
| Puppies/adolescent/adult (n) | 0 | 0 | 1 | 0 | 0 | 1 | |||||||
| Nose/tonsils/both (n) | 0 | 0 | 1 | 0 | 0 | 1 | |||||||
| Acute/chronic (n) | 0 | 1 | 0 | 1 | |||||||||
| CDV | Dogs (n) | 1 | 1 | 0 | 0 | ||||||||
| Puppies/adolescent/adult (n) | 0 | 0 | 1 | 0 | 0 | 1 | |||||||
| Nose/tonsils/both (n) | 0 | 1 | 0 | 0 | 1 | 0 | |||||||
| Acute/chronic (n) | 0 | 1 | 0 | 1 | |||||||||
| CIV | Dogs (n) | 0 | 0 | 0 | 0 | ||||||||
CIRD Canine infectious respiratory disease, CRCoV Canine respiratory coronavirus, CPiV Canine parainfluenza virus, CAV‐2 Canine adenovirus type‐2, CDV Canine distemper virus, CIV Canine influenza virus, Group A Privately owned diseased dogs, Group B Kennelled diseased dogs, Group C Healthy control group
Significantly more acutely diseased dogs (P<0.039) and dogs from the adolescent subgroup (P<0.002) tested positive for CRCoV. Samples derived from the nose provided detection of viral nucleic acid in 90.6% of the positive dogs
*
Information not available for one dog of group A